Eptifibatide (monoacetate)

Eptifibatide (monoacetate)

• CAS Number: 1248559-53-6
• UNSPSC Description: Eptifibatide monoacetate is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity[1].
• Target Antigen: Integrin
• Type: Peptides
• Related Pathways: Cytoskeleton
• Applications: Neuroscience-Neuromodulation
• Field of Research: Cardiovascular Disease
• Assay Protocol: https://www.medchemexpress.com/eptifibatide-monoacetate.html
• Solubility: 10 mM in DMSO
• Smiles: O=C([C@H](CC1=CNC2=CC=CC=C12)NC([C@H](CC(O)=O)NC(CNC([C@H](CCCCNC(N)=N)N3)=O)=O)=O)N4CCC[C@]4(C(N[C@H](C(N)=O)CSSCCC3=O)=O)[H].CC(O)=O
• Molecular Weight: 892.01
• References & Citations: [1]Gilchrist IC, et al. Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide. Clin Pharmacokinet. 2003;42(8):703-20.
• Shipping Conditions: Room temperature
• Clinical Information: Launched